Companies: 10,795·Total market cap: $144.5T
Lucy Scientific Discovery Inc.

Lucy Scientific Discovery Inc.

LSDINASDAQHealthcare
$0.51
$-0.16(-23.29%)
Market Cap$906910
P/E Ratio
52W High$12.8
52W Low$0.44
Overview

Lucy Scientific Discovery Inc. (LSDI) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lsdi · pe ratio · data through Jun 30, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Lucy Scientific Discovery Inc. (LSDI) measures how much investors pay for each dollar of the company's trailing earnings. LSDI's current PE ratio of N/A is calculated by dividing its stock price of $0.51 by its TTM earnings per share of -$0.71.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-06-30

Forward P/E
N/A
FY2026 est. EPS $-0.80
Based on 1 analyst
EPS (TTM)
-$0.71
TTM · diluted EPS
PEG Ratio
0.01
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lucy Scientific Discovery Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2023 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc.You
LSDI
$1MN/A-$0.71
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc.
ACOR
$1MN/A-$203.59
Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc.
AXDX
$1MN/A-$2.15
Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc.
CYTH
$24MN/A-$1.23
HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc.
HTGMQ
$0MN/A-$24.28
Impel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc.
IMPL
$1MN/A-$5.52
Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc.
NEPTF
$0MN/A-$8190.15

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-06-30Latest
FY2023
$-0.71
2022-06-30
FY2022
$-0.38
2021-06-30
FY2021
$-0.44
2020-06-30
FY2020
$-0.19

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Lucy Scientific Discovery Inc. (LSDI) measures how much investors pay for each dollar of the company's trailing earnings. LSDI's current PE ratio of N/A is calculated by dividing its stock price of $0.51 by its TTM earnings per share of -$0.71.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.51 ÷ -$0.71 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

LSDI pe ratio · 6 questions

LSDI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.51 and TTM EPS of -$0.71. Data sourced from Financial Modeling Prep via LSDI's SEC 10-K and 10-Q filings.

LSDI PE ratioWhat is LSDI PE ratioCurrent PE ratio of LSDILSDI PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lucy Scientific Discovery Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09